FDA — authorised 19 August 2005
- Marketing authorisation holder: ALCON PHARMS LTD
- Status: approved
FDA authorised Nevanac on 19 August 2005
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 19 August 2005.
ALCON PHARMS LTD holds the US marketing authorisation.